INSIDE PHARMA

INSIDE PHARMA

Share this post

INSIDE PHARMA
INSIDE PHARMA
BROOK JACKSON SPILT THE BEANS ON LACK OF PFIZER OVERSIGHT

BROOK JACKSON SPILT THE BEANS ON LACK OF PFIZER OVERSIGHT

Indisputable evidence that Pfizer was asleep at the 'injections' wheel.

Hedley Rees's avatar
Hedley Rees
Nov 29, 2024
∙ Paid
26

Share this post

INSIDE PHARMA
INSIDE PHARMA
BROOK JACKSON SPILT THE BEANS ON LACK OF PFIZER OVERSIGHT
4
5
Share

[Note: this is a recycle from February 18, 2022]

BROOK JOINS VENTAVIA

On September 7, 2020, Brook Jackson began her employment with Ventavia Research Group (“Ventavia”) as a Regional Director.

Ventavia is not owned by Pfizer. Pfizer had offloaded the clinical trial work onto what is known as a Contract Research Organisation (CRO).

CROs work on a fee-for-service basis, and they have grown like topsy over the last 30 or so years, covering all aspects of work relating to preclinical testing and trials in humans.

CROs quality of work varies greatly, and unfortunately for Brook, she had been recruited into one at the bottom of the pile.

HORRIFIC DOESN’T EVEN COME CLOSE

Describing what Brook discovered at Ventavia as ‘horrific’ doesn’t come close to it—the violations and malpractice was unimaginable.

In a direct message on Twitter, Brook told me:

Pfizer pushed Ventavia to enroll as many patients as possible in the vaccine trial as quickly as possible. Ventavia was compensated by Pfizer mainly on a …

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Hedley Rees
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share